atracurium has been researched along with Autosomal Dominant Myotubular Myopathy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campoy, L; Gleed, RD; Martin-Flores, M; Paré, MD | 1 |
| Costi, D; van der Walt, JH | 1 |
2 other study(ies) available for atracurium and Autosomal Dominant Myotubular Myopathy
| Article | Year |
|---|---|
Neuromuscular blocking effects of cisatracurium and its antagonism with neostigmine in a canine model of autosomal-recessive centronuclear myopathy.
Topics: Anesthesia Recovery Period; Anesthesia, General; Animals; Atracurium; Cholinesterase Inhibitors; Disease Models, Animal; Dogs; Monitoring, Intraoperative; Myopathies, Structural, Congenital; Neostigmine; Neuromuscular Blockade; Neuromuscular Blocking Agents; Neuromuscular Junction | 2015 |
General anesthesia in an infant with X-linked myotubular myopathy.
Topics: Anesthesia, General; Anesthetics, Intravenous; Atracurium; Dose-Response Relationship, Drug; Electric Stimulation; Fentanyl; Fundoplication; Gastrostomy; Genetic Diseases, X-Linked; Humans; Infant; Intubation, Intratracheal; Male; Myopathies, Structural, Congenital; Neuromuscular Nondepolarizing Agents; Propofol; Respiration, Artificial | 2004 |